These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33010443)

  • 1. Comparison of clinical outcomes of patients infected with KPC- and NDM-producing Enterobacterales: a retrospective cohort study.
    Seo H; Kim HJ; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Jung J
    Clin Microbiol Infect; 2021 Aug; 27(8):1167.e1-1167.e8. PubMed ID: 33010443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study.
    Dickstein Y; Solter E; Schwartz D; Nutman A; Harevrich I; Wulffhart L; Carmeli Y; Schwaber MJ
    Clin Microbiol Infect; 2021 Oct; 27(10):1518.e1-1518.e3. PubMed ID: 34111587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of the Relative Load of KPC-Producing Klebsiella pneumoniae within the Intestinal Microbiota in a Prospective Cohort of Colonized Patients.
    Pérez-Nadales E; M Natera A; Recio-Rufián M; Guzmán-Puche J; Marín-Sanz JA; Martín-Pérez C; Cano Á; Castón JJ; Elías-López C; Machuca I; Gutiérrez-Gutiérrez B; Martínez-Martínez L; Torre-Cisneros J
    Microbiol Spectr; 2022 Aug; 10(4):e0272821. PubMed ID: 35766500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area.
    Falcone M; Giordano C; Leonildi A; Galfo V; Lepore A; Suardi LR; Riccardi N; Barnini S; Tiseo G
    Clin Infect Dis; 2024 May; 78(5):1111-1119. PubMed ID: 38036465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Identification of OXA-48-like, KPC, NDM, and VIM Carbapenemase-Producing Enterobacteriaceae From Culture: Evaluation of the RESIST-4 O.K.N.V. Multiplex Lateral Flow Assay.
    Song W; Park MJ; Jeong S; Shin DH; Kim JS; Kim HS; Kim HS; Lee N; Hong JS; Jeong SH
    Ann Lab Med; 2020 May; 40(3):259-263. PubMed ID: 31858767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study).
    Falcone M; Tiseo G; Galfo V; Giordano C; Leonildi A; Marciano E; De Simone P; Biancofiore G; Boggi U; Barnini S; Menichetti F;
    Clin Microbiol Infect; 2022 Feb; 28(2):298.e1-298.e7. PubMed ID: 34197935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
    Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
    Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
    Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
    Shortridge D; Kantro V; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Outcomes of Patients Colonized with KPC and NDM Carbapenemase-Producing Enterobacterales.
    Saidel-Odes L; Sagi O; Troib S; Leeman H; Nativ R; Schlaeffer-Yosef T; Azulay H; Nesher L; Borer A
    Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Irish outbreak of New Delhi metallo-β-lactamase (NDM)-1 carbapenemase-producing Enterobacteriaceae: increasing but unrecognized prevalence.
    O'Connor C; Cormican M; Boo TW; McGrath E; Slevin B; O'Gorman A; Commane M; Mahony S; O'Donovan E; Powell J; Monahan R; Finnegan C; Kiernan MG; Coffey JC; Power L; O'Connell NH; Dunne CP
    J Hosp Infect; 2016 Dec; 94(4):351-357. PubMed ID: 27624807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and epidemiological features of patients colonised by different types of carbapenemase-producing Enterobacterales.
    Assis R; Lasnoy M; Adler A
    J Glob Antimicrob Resist; 2021 Sep; 26():108-113. PubMed ID: 34118482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance.
    Khan MA; Mohamed AM; Faiz A; Ahmad J
    J Infect Dev Ctries; 2019 Apr; 13(4):334-341. PubMed ID: 32045378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018.
    Huang YS; Tsai WC; Li JJ; Chen PY; Wang JT; Chen YT; Chen FJ; Lauderdale TL; Chang SC
    Sci Rep; 2021 Jan; 11(1):2609. PubMed ID: 33510280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
    Di Pilato V; Principe L; Andriani L; Aiezza N; Coppi M; Ricci S; Giani T; Luzzaro F; Rossolini GM
    Clin Microbiol Infect; 2023 Apr; 29(4):537.e1-537.e8. PubMed ID: 36414199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Disk carbapenemase test using improved disks for rapid detection and differentiation of clinical isolates of carbapenemase-producing Enterobacterales.
    Lee H; Kim JL; Jung DH; Seo Y; Kim M; Yong D; Lee K; Chong Y
    J Infect Chemother; 2021 Aug; 27(8):1205-1211. PubMed ID: 33888420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
    Huang YT; Kuo YW; Lee NY; Tien N; Liao CH; Teng LJ; Ko WC; Hsueh PR;
    Microbiol Spectr; 2022 Feb; 10(1):e0172821. PubMed ID: 35019772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.
    Spyropoulou A; Papadimitriou-Olivgeris M; Bartzavali C; Vamvakopoulou S; Marangos M; Spiliopoulou I; Anastassiou ED; Christofidou M
    J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible
    Kazmierczak KM; Karlowsky JA; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0200020. PubMed ID: 33972241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.